David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Quantum Corp
QMCO
$915M
| $2.23M | ﹤0.01% |
8,710
-373
| -4% | -$98.5K |
|
|
ATW
1902
DELISTED
Atwood Oceanics
ATW
| $2.23M | ﹤0.01% |
79,146
-215,778
| -73% | -$6.42M |
|
|
COHR
1903
DELISTED
Coherent Inc
COHR
| $2.22M | ﹤0.01% |
34,215
+25,884
| +311% | +$1.61M |
|
1904
PUT
RH
RH
$2.81B
| $2.22M | ﹤0.01% |
22,400
-10,900
| -33% | -$989K |
|
|
REMY
1905
DELISTED
REMY INTL INC NEW COMMON
REMY
| $2.22M | ﹤0.01% |
+100,000
| New | +$2.17M |
|
|
CSC
1906
PUT
DELISTED
Computer Sciences
CSC
| $2.21M | ﹤0.01% |
80,445
-96,581
| -55% | -$2.67M |
|
1907
Helix Energy Solutions
HLX
$1.44B
| $2.21M | ﹤0.01% |
+147,681
| New | +$2.49M |
|
|
ILG
1908
DELISTED
ILG, Inc Common Stock
ILG
| $2.21M | ﹤0.01% |
84,268
-2,767
| -3% | -$68.2K |
|
|
NTT
1909
DELISTED
Nippon Telegraph & Telephone
NTT
| $2.2M | ﹤0.01% |
71,469
-184,517
| -72% | -$5.47M |
|
1910
OSI Systems
OSIS
$3.36B
| $2.2M | ﹤0.01% |
29,621
-1,609
| -5% | -$115K |
|
|
EMKR
1911
DELISTED
Emcore Corp
EMKR
| $2.2M | ﹤0.01% |
40,416
+720
| +2% | +$38.5K |
|
1912
Wipro
WIT
$18.1B
| $2.2M | ﹤0.01% |
879,349
+321,450
| +58% | +$787K |
|
1913
Interactive Brokers
IBKR
$44B
| $2.19M | ﹤0.01% |
258,132
-80,860
| -24% | -$642K |
|
|
DFS
1914
PUT
DELISTED
Discover Financial Services
DFS
| $2.19M | ﹤0.01% |
38,900
-131,500
| -77% | -$7.79M |
|
|
USG
1915
DELISTED
Usg
USG
| $2.19M | ﹤0.01% |
81,937
-58,403
| -42% | -$1.66M |
|
1916
Gyre Therapeutics
GYRE
$705M
| $2.19M | ﹤0.01% |
935
| – | – |
|
1917
Xerox
XRX
$391M
| $2.19M | ﹤0.01% |
64,533
-14,869
| -19% | -$525K |
|
|
AAT
1918
American Assets Trust
AAT
$1.4B
| $2.18M | ﹤0.01% |
50,384
-23,752
| -32% | -$1.02M |
|
1919
PUT
Eli Lilly
LLY
$1.06T
| $2.18M | ﹤0.01% |
30,000
-299,000
| -91% | -$21.3M |
|
|
MESG
1920
DELISTED
XURA INC COM (DE)
MESG
| $2.18M | ﹤0.01% |
110,523
-23,263
| -17% | -$429K |
|
1921
DHI Group
DHX
$193M
| $2.18M | ﹤0.01% |
243,954
-246,671
| -50% | -$2.24M |
|
1922
PUT
DaVita
DVA
$11.5B
| $2.17M | ﹤0.01% |
26,700
-17,500
| -40% | -$1.34M |
|
|
TUMI
1923
DELISTED
TUMI HLDGS INC COM
TUMI
| $2.17M | ﹤0.01% |
88,734
-14,149
| -14% | -$322K |
|
|
STJ
1924
DELISTED
St Jude Medical
STJ
| $2.17M | ﹤0.01% |
33,100
+26,823
| +427% | +$1.78M |
|
1925
PUT
O'Reilly Automotive
ORLY
$72.4B
| $2.16M | ﹤0.01% |
150,000
-1,143,000
| -88% | -$15.4M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.